Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.
Open | $1.400 |
Close | $1.310 |
Volume / Avg. | 382.885K / 645.208K |
Day Range | 1.270 - 1.430 |
52 Wk Range | 0.945 - 3.110 |
Market Cap | $116.998M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 3.41% |
Days to Cover | 11.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.
Other companies in Immunic’s space includes: Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX) and Cellectar Biosciences (NASDAQ:CLRB).
The latest price target for Immunic (NASDAQ: IMUX) was reported by Brookline Capital on Friday, April 5, 2024. The analyst firm set a price target for 10.00 expecting IMUX to rise to within 12 months (a possible 668.64% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Immunic (NASDAQ: IMUX) is $1.301 last updated April 15, 2024 at 7:38 PM EDT.
There are no upcoming dividends for Immunic.
Immunic’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Immunic.
Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.